|
[1]Ferenci P, Lockwood A, Mullen K, et al.Hepatic encepha-lopathy-definition, nomenclature, diagnosis, and quantifica-tion:final report of the working party at the 11th World Con-gresses of Gastroenterology, vienna, 1998[J].Hepatology, 2002, 35 (3) :716-721.
|
|
[2]Rose C, Kresse W, Kettenmann H.Acute insult of ammonialeads to calcium-dependent glutamate release from culturedastrocytes, an effect of Ph[J].J Biol Chem, 2005, 280 (22) :20937-20944.
|
|
[3]Shawcross DL, Davies NA, Williams R, et al.Systemic in-flammatory response exacerbates the neuropsychologicaleffects of induced hyperammonemia in cirrhosis[J].J Hepa-tol, 2004, 40 (2) :247-254.
|
|
[4]Bajaj JS, Saeian K, Verber MD, et al.Inhibitory control testis a simple method to diagnose minimal hepatic encephalopa-thy and predict development of overt hepatic encephalopathy[J].Am J Gastroenterol, 2007, 102 (4) :754-760.
|
|
[5]Mardini H, Saxby BK, Record CO.Computerized psycho-metric testing in minimal encephalopathy and modulation bynitrogen challenge and liver transplant[J].Gastroenterolo-gy, 2008, 135 (5) :1582-1590.
|
|
[6]Plauth M, CabréE, Riggio O, et al.ESPEN Guidelines onEnteral Nutrition:Liver disease[J].Clin Nutr, 2006, 25 (2) :285-294.
|
|
[7]Muto Y, Sato S, Watanabe A, et al.Effects of oral branched-chain amino acid granules on event-free survival in pa-tients with liver cirrhosis[J].Clin Gastroenterol Hepatol, 2005, 3 (7) :705-713.
|
|
[8]Bass NM, Mullen KD, Sanyal A, et al.Rifaximin treatmentin hepatic encephalopathy[J].N Engl J Med, 2010, 362 (12) :1071-1081.
|
|
[9]Stewart CA, Malinchoc M, Kim WR, et al.Hepatic encepha-lopathy as a predictor of survival in patients with end-stageliver disease[J].Liver Transpl, 2007, 13 (10) :1366-1371.
|
|
[10]Albrecht J.Cyclic GMP in blood and minimal hepatic enceph-alopathy:fine-tuning of the diagnosis[J].J Mol Med, 2007, 85 (3) :203-205.
|
DownLoad: